Hypoxia skews dendritic cells to a T helper type 2-stimulating phenotype and promotes tumour cell migration by dendritic cell-derived osteopontin

Immunology

Volumn 128, Issue 1 PART 2, 2009, Pages

  Yang, Meixiang ^a,c   Ma, Chunhong ^c   Liu, Shuxun ^b   Sun, Jintang ^a   Shao, Qianqian ^a   Gao, Wenjuan ^a   Zhang, Yan ^a   Li, Zewu ^a   Xie, Qi ^a   Dong, Zhaogang ^a   Qu, Xun ^a  

^a SHANDONG UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Cancer; Dendritic cells; Hypoxia; T helper type 2

Indexed keywords

OSTEOPONTIN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL FUNCTION; CELL HYPOXIA; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HYPOXIA; METASTASIS; MIXED LYMPHOCYTE REACTION; OXYGEN SUPPLY; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; TH2 CELL; TUMOR CELL; TUMOR GROWTH;

ANOXIA; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL MOVEMENT; CYTOKINES; DENDRITIC CELLS; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; NEOPLASMS; OSTEOPONTIN; PHAGOCYTOSIS; SIGNAL TRANSDUCTION; TH2 CELLS; TUMOR ESCAPE; UP-REGULATION;

EID: 68249153389     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.02954.x     Document Type: Article

References (40)

1. Caldwell CC, Kojima H, Lukashev D, Armstrong J, Farber M, Apasov SG, Sitkovsky MV. Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J Immunol 2001 167 : 6140 9.
2. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989 49 : 6449 65.
3. Brahimi-Horn MC, Pouyssegur J. The hypoxia-inducible factor and tumor progression along the angiogenic pathway. Int Rev Cytol 2005 242 : 157 213.
4. Vaupel P, Briest S, Hockel M. Hypoxia in breast cancer: pathogenesis, characterization and biological/therapeutic implications. Wien Med Wochenschr 2002 152 : 334 42.
5. Okunieff P, Fenton B, Chen Y. Past, present, and future of oxygen in cancer research. Adv Exp Med Biol 2005 566 : 213 22.
6. Hockel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001 93 : 266 76.
7. Vaupel P, Harrison L. Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist 2004 9 (Suppl. 5 4 9.
8. Biselli R, Le Moli S, Matricardi PM, Farrace S, Fattorossi A, Nisini R, D'Amelio R. The effects of hypobaric hypoxia on specific B cell responses following immunization in mice and humans. Aviat Space Environ Med 1991 62 : 870 4.
9. Zuckerberg AL, Goldberg LI, Lederman HM. Effects of hypoxia on interleukin-2 mRNA expression by T lymphocytes. Crit Care Med 1994 22 : 197 203.
10. Thiel M, Chouker A, Ohta A et al. Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol 2005 3 : e174.
11. Yun JK, McCormick TS, Villabona C, Judware RR, Espinosa MB, Lapetina EG. Inflammatory mediators are perpetuated in macrophages resistant to apoptosis induced by hypoxia. Proc Natl Acad Sci USA 1997 94 : 13903 8.
12. Segal AW, Geisow M, Garcia R, Harper A, Miller R. The respiratory burst of phagocytic cells is associated with a rise in vacuolar pH. Nature 1981 290 : 406 9.
13. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000 18 : 767 811.
14. Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003 3 : 984 93.
15. Moser M, Murphy KM. Dendritic cell regulation of TH1-TH2 development. Nat Immunol 2000 1 : 199 205.
16. Moser M. Regulation of Th1/Th2 development by antigen-presenting cells in vivo. Immunobiology 2001 204 : 551 7.
17. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995 182 : 389 400.
18. Reis e Sousa C, Stahl PD, Austyn JM. Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med 1993 178 : 509 19.
19. Kalinski P, Hilkens CM, Wierenga EA, Kapsenberg ML. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today 1999 20 : 561 7.
20. Triozzi PL, Khurram R, Aldrich WA, Walker MJ, Kim JA, Jaynes S. Intratumoral injection of dendritic cells derived in vitro in patients with metastatic cancer. Cancer 2000 89 : 2646 54.
21. Renkl AC, Wussler J, Ahrens T et al. Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. Blood 2005 106 : 946 55.
22. Chen Z, Gordon JR, Zhang X, Xiang J. Analysis of the gene expression profiles of immature versus mature bone marrow-derived dendritic cells using DNA arrays. Biochem Biophys Res Commun 2002 290 : 66 72.
23. Bain C, Fatmi A, Zoulim F, Zarski JP, Trepo C, Inchauspe G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 2001 120 : 512 24.
24. Chen T, Guo J, Yang M et al. Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression. Blood 2004 103 : 413 21.
25. Campos-Martin Y, Colmenares M, Gozalbo-Lopez B, Lopez-Nunez M, Savage PB, Martinez-Naves E. Immature human dendritic cells infected with Leishmania infantum are resistant to NK-mediated cytolysis but are efficiently recognized by NKT cells. J Immunol 2006 176 : 6172 9.
26. Barkley D, Allard S, Feldmann M, Maini RN. Increased expression of HLA-DQ antigens by interstitial cells and endothelium in the synovial membrane of rheumatoid arthritis patients compared with reactive arthritis patients. Arthritis Rheum 1989 32 : 955 63.
27. Boissel N, Rousselot P, Raffoux E et al. Defective blood dendritic cells in chronic myeloid leukemia correlate with high plasmatic VEGF and are not normalized by imatinib mesylate. Leukemia 2004 18 : 1656 61.
28. Qu X, Yang MX, Kong BH et al. Hypoxia inhibits the migratory capacity of human monocyte-derived dendritic cells. Immunol Cell Biol 2005 83 : 668 73.
29. Cramer T, Yamanishi Y, Clausen BE et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 2003 112 : 645 57.
30. Penna G, Vulcano M, Sozzani S, Adorini L. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum Immunol 2002 63 : 1164 71.
31. Guriec N, Daniel C, Le Ster K, Hardy E, Berthou C. Cytokine-regulated expression and inhibitory function of FcgammaRIIB1 and -B2 receptors in human dendritic cells. J Leukoc Biol 2006 79 : 59 70.
32. O'Mahony L, O'Callaghan L, McCarthy J et al. Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans. Am J Physiol Gastrointest Liver Physiol 2006 290 : G839 45.
33. Hume DA. Comment on "CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes". J Immunol 2006 177 : 2035 6.
34. Hansson M, Lundgren A, Elgbratt K, Quiding-Jarbrink M, Svennerholm AM, Johansson EL. Dendritic cells express CCR7 and migrate in response to CCL19 (MIP-3beta) after exposure to Helicobacter pylori. Microbes Infect 2006 8 : 841 50.
35. Zhao W, Darmanin S, Fu Q et al. Hypoxia suppresses the production of matrix metalloproteinases and the migration of human monocyte-derived dendritic cells. Eur J Immunol 2005 35 : 3468 77.
36. Panther E, Corinti S, Idzko M, Herouy Y, Napp M, la Sala A, Girolomoni G, Norgauer J. Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood 2003 101 : 3985 90.
37. Serrano-Gomez D, Leal JA, Corbi AL. DC-SIGN mediates the binding of Aspergillus fumigatus and keratinophylic fungi by human dendritic cells. Immunobiology 2005 210 : 175 83.
38. Carter RW, Thompson C, Reid DM, Wong SY, Tough DF. Induction of CD8+ T cell responses through targeting of antigen to Dectin-2. Cell Immunol 2006 239 : 87 91.
39. Jantsch J, Chakravortty D, Turza N et al. Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function. J Immunol 2008 180 : 4697 705.
40. Rodrigues LR, Teixeira JA, Schmitt FL, Paulsson M, Lindmark-Mansson H. The role of osteopontin in tumor progression and metastasis in breast cancer. Cancer Epidemiol Biomarkers Prev 2007 16 : 1087 97.